Rentschler Biopharma provides contract development and manufacturing organization (CDMO) services for biopharmaceuticals, including advanced therapies. The company is involved in bioprocess development and manufacturing of biopharmaceuticals.

Rentschler Biopharma

Domain Not Resolving

HSTS

Content Delivery Network

Microsoft Exchange Online

Apache

Office 365 Mail

Microsoft Azure DNS

Apple Mobile Web App Capable

Apple Mobile Web App Status Bar Style

Assistant to the Board

Tatjana Bauermeister

Quality

Dawn Rossi

Vice President, Site Head

Mark Caswell

Information Technology

Aled Charles

Director of Cell Culture Process Development

Ashley Groves

Director Automation and Digitalization

Astrid Friedrich

Director MSAT USP Early Clinical Manufacturing

Benjamin Weis

SR Director of Finance, Treasurer

Bob Donovan

Director, Operational Excellence

Bryan Wells

Director, Quality Control Microbiology

Christine Stevens

Christiane Bardroff

COO, Chief Operating Officer

Dr. Christian Schetter

Chief Scientific Officer

Peter Rogge

Project Manager & Senior Advisor Academy

Guenter Stempfer

Head Global Strategic Development

Gunnar Voss von Dahlen

Christian Hunzinger

Vp, Analytical Science

Patrick Cushing

VP Operations

Europe Biopharma Companies

Germany Companies (Top 10K)

Europe, Middle East, and Africa (EMEA) Early Stage Companies With More Than 100 Employees

Baden-Wurttemberg Companies With Less Than $10M in Revenue

What unites us at Rentschler, is the passion for what they do. As a full-service CDMO they are your outsourcing partner for the bioprocess development, cGMP manufacturing and aseptic filling of biopharmaceuticals as well as for the elaboration of approval strategies for your products. Thanks to their many years of experience, the quality of their consulting services, and their expertise in finding solutions, they are among the top suppliers in their field.

Founded in 1927, Rentschler is a privately owned and independent company. Their company structure guarantees rapid decision-making and efficient, smooth-running processes, and consequently keeping project timelines.
Already in the early beginnings of biotechnology, Rentschler has built up a reputation with the development of different Interferon products (Fiblaferon, Polyferon). 

Nowadays, their attention is firmly focused on your products. For the success of your project they can refer to their experience in various molecules like antibodies, fusion proteins or enzymes. Thanks to their focus on innovations, they are always on the cutting edge of technologies.

Series A - Rentschler Biopharma SE

Computer and Software Services and Scientific Services

Laupheim

Baden-Wurttemberg

Germany

Europe

Rentschler Biopharma SE

Rentschler Biopharma announces largest single investment at its headquarters in Germany

Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational

Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Rentschler Biopharma Takes Home the Gold in 20th Annual Team Massachusetts Economic Impact Awards

Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023

United States

North America

Austria

Philippines

Asia

Lithuania

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:07 PM	39ae4453
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:07 PM	3e9aa07f
crunchbase trigger	general	Nov 12, 2024 12:52 PM	8707b572
crunchbase profile	general	Nov 12, 2024 8:49 PM	3a099e3a
li profile	general
translate crunchbase fundingrounds	general	Nov 12, 2024 9:22 PM	dbabd377
peers	general	Sep 27, 2024 4:07 PM	0d0bbc16
news basic	general	Sep 27, 2024 4:07 PM	26a6154d
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:RENTSCHLER-BIOPHARMA

Rentschler Biopharma